✦ LIBER ✦

Safety of switching systemic steroids to budesonide modified-release capsules in steroid-dependent patients with inactive Crohn's disease

✍ Scribed by Cortot, Antoine; Colombel, Jean-Frederic; Rutgeerts, Paul; Lauritsen, Karsten; Malchow, Helmuth; Hamling, Jens; Tabea, Krankenhaus; Winter, Trevor; Gossum, Andre Van; Pettersson, Eva

Book ID: 124122941
Publisher: Elsevier Science
Year: 2001
Tongue: English
Weight: 172 KB
Volume: 120
Category: Article
ISSN: 0016-5085
DOI: 10.1016/S0016-5085(08)83732-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effect of switching to budesonide on the

Effect of switching to budesonide on the quality of life of patients with steroid-dependent Crohn's disease

✍ Cortot, Antoine; Colombel, Jean-Frederic; Rutgeerts, Paul; Lauritsen, Karsten; M 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 174 KB

Budesonide is superior to mesalazine in

Budesonide is superior to mesalazine in maintaining disease remission for patients with steroid-dependent Crohn's disease

✍ G.J. Mantzaris; K. Petraki; E. Chadio; E. Archavlis; A. Christidou; G. Triantafy 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 168 KB

A comparison of the effect of budesonide

A comparison of the effect of budesonide and mesalamine on the quality of life in patients with steroid-dependent Crohn's disease

✍ Mantzaris, Gerassimos J.; Petraki, K; Sfakianakis, M; Kourtessas, D; Chadio-Iord 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 339 KB

Sefety of retreatment with antisense to

Sefety of retreatment with antisense to icam-1 (isis 2302) in patients with steroid-dependent Crohn's disease

✍ Yacyshyn, B.R.; Bowen-Yacyshyn, M.B.; Tami, J.; Sahba, B.; Shanahan, W. 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 172 KB

A six-month open label assessment of ste

A six-month open label assessment of steroid sparing properties of CDP571, a humanized antibody to TNFA in steroid dependent patients with Crohn's disease

✍ Feagan, Brian G.; Hanauer, Stephen B.; Cominelli, F.; Sutherland, Lloyd R.; Elso 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 182 KB

A randomized, double-blind, placebo-cont

A randomized, double-blind, placebo-controlled, multi-center trial of the engineered human anti body to TNF (CDP571) for steroid sparing and maintenance of remission in patients with steroid-dependent Crohn's disease

✍ Feagan, Brian G.; Sandborn, William J.; Baker, J.P.; Cominelli, F.; Sutherland, 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 165 KB